ENTRY       D10455                      Drug
NAME        Pneumococcal 13-valent conjugate vaccine;
            Prevnar 13 (TN);
            Prevenar 13 (TN)
PRODUCT     PREVNAR 13 (Wyeth Pharmaceutical Division of Wyeth Holdings LLC)
REMARK      Therapeutic category: 6311
            ATC code: J07AL02
            Product: D10455<JP/US>
EFFICACY    Active immunization (pneumococcal)
  DISEASE   Prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F [DS:H01321]
COMMENT     Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J07 VACCINES
               J07A BACTERIAL VACCINES
                J07AL Pneumococcal vaccines
                 J07AL02 Pneumococcus, purified polysaccharides antigen conjugated
                  D10455  Pneumococcal 13-valent conjugate vaccine &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Vaccines
               Pneumococcal
                Pneumococcal Conjugate Vaccine, 13 Valent
                 D10455  Pneumococcal 13-valent conjugate vaccine
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               631  Vaccines
                6311  Bacterial vaccines
                 D10455  Pneumococcal 13-valent conjugate vaccine
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10455
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10455
DBLINKS     PubChem: 172232548
///
